LIMINATUS PHARMA, INC. — Key Metrics
9 years of history · ending 2025-12-31 · SEC EDGAR
QuarterlyAnnual
EPS (Diluted)↓-112.0% -$0
$-0
Book Value Per Share↑+62.6% +$1
$-0
Free Cash Flow Per Share↓-406.5% -$0
$-0
Return on Equity↑+159.7pts
178.1%
Return on Assets↓-1034.7pts
-1100.3%
Return on Invested Capital↑+27.2pts
40.9%
Current Ratio↓-77.2% -$0
0.05
Quick Ratio↓-77.2% -$0
0.05